Sensory Challenge Protocol
OtherMeasurement of electrodermal activity in response to sensation
NCT Number: NCT02646696
The purpose of this study is tTho establish test-retest reliability of electrodermal markers used to quantify physiologic response to sensation using the Sensory Challenge Protocol in children with and without Autism Spectrum Disorder (ASD).
Looking for future studies?
Notify Me4 year–11 year
Male
Observational
This methodological research design is a prospective exploratory test-retest design assessing the use of electrodermal activity (EDA) as an index of sensory processing. EDA will be measured using skin conductance response (SCR). The purpose of this study is to investigate if using EDA is a reliable measure over time within the context of response to sensation. Scores from test one and test two of each subject will be correlated to determine reliability of EDA measure. Reliability in this context will establish the utility of EDA as an index of sensory processing. Testing will occur two times within a six week period.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Boys ages 4 - 11 years old.
Exclusion criteria
Measurement of electrodermal activity in response to sensation
Time frame: within six weeks
Barpak Geriatric Health Services, Inc. d/b/a Barpak Occupational Therapy
Other
Reliability of Electrodermal Activity: Quantifying Sensory Processing in Children With Autism Spectrum Disorder
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07277101
Autism Spectrum Disorder, Autistic Disorder
Shanghai, China
View Trial DetailsNCT06361147
Autism Spectrum Disorder, Child Development Disorders, Pervasive
Heraklion, Crete, Greece
View Trial DetailsNCT06508515
Autism Spectrum Disorder, Child Development Disorders, Pervasive
Seattle, Washington, United States
View Trial DetailsNCT06557902
Autism Spectrum Disorder, Child Development Disorders, Pervasive
Orlando, Florida, United States
View Trial Details